parkeri by BSO in macrophages did not result in bacteriolysis (Fig
Bastos-Moreira Y, Argaw A, Dailey-Chwalibg T et al (2024a) Prenatal ochratoxin A exposure, birth outcomes and infant growth in rural Burkina Faso: a human biomonitoring sub-study from the MISAME-III trial
Last August, Lilly impressed investors with positive data in its third Phase III for orfoglipron showing that patients taking the pill lowered their weight by an average of 10.5% (22.9 lbs) vs
It was originally developed at Washington State University and has been patented for potential use in Alzheimer's disease and other neurodegenerative conditions
Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study
J Am Acad Dermatol 44:10481049 Kumar C, Sharma D, Pandita A, Shastri S (2015) Congenital lingual melanotic macule: rare entity in infants